|
|
 |
 |
|
|
|
 |
 |
|
 |
|
|
|
Join CBCAN
|
We invite you to join CBCAN, no charge, by registering on-line.
By joining CBCAN this will allow you to join the Discussion Forum, download the Bladder Cancer Basics brochure, as well, we will keep you informed about future meetings in your area and will ensure that you receive our Newsletter when available
|
|
|
Bladder Cancer Facts
|
In 2010, Statistics Canada estimates that 7,100 people in Canada will be diagnosed with bladder cancer, making it the 6th most common cancer in Canada (5th most common among men, with 5,300 cases and 12th most common among women with 1,800 cases).
With a recurrence rate of nearly 80%, bladder cancer is the most expensive cancer to treat on a per patient basis, and the high recurrence rate raises many issues affecting quality of life because of its persistence
|
|
|
|
|
|
Medical Advisory Board
CBCAN’s Medical Advisory Board is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in Canada.
The following are the founding members of our Medical Advisory Board:
Chairperson:
Wes Kassouf, MD, CM, FRCSC, McGill University, Montreal QC
Armen Aprikian, MD, FRCSC, McGill University, Montreal QC
Peter Black, MD, FRCSC, University of British Columbia, Vancouver BC
Michel Carmel, MD, FRCSC, University of Sherbrook, Sherbrook QC
Joe Chin, MD, FRCSC, University of Western Ontario, London ON
Darrel Drachenberg, MD, FRCSC, University of Manitoba, Winnipeg MB
Yves Fradet, MD, FRCSC, Laval University, Laval QC
Michael Jewett, MD, FRCSC, FACS University of Toronto, Toronto ON
Ron Moore, MD, FRCSC, University of Alberta, Edmonton AB
Chris Morash, MD, FRCSC, University of Ottawa, Ottawa ON
Ricardo Rendon, MD, FRCSC, Dalhousie University, Halifax NS
Fred Saad, MD, FRCSC, CHUM, Montreal QC
Bobby Sheyagan, MD, FRCSC, McMasters University, Hamilton ON
|
